Advertisement

GI & Endoscopy

FDA has announced it has approved the first genetic test that can help some colorectal cancer patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation, according…

Advertisement
Advertisement